Tenaya Therapeutics, Inc.
TNYA
$0.73
$0.00-0.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -86.37% | 28.26% | 15.36% | 20.91% | 20.89% |
| Total Depreciation and Amortization | -18.52% | -33.75% | -12.54% | -11.28% | -1.84% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 453.22% | -36.85% | -20.02% | -25.55% | -18.67% |
| Change in Net Operating Assets | 1,172.19% | -33.42% | 186.20% | 30.07% | 151.93% |
| Cash from Operations | 77.25% | 16.78% | 24.19% | 21.36% | 33.89% |
| Capital Expenditure | -11.97% | 97.13% | 67.16% | 85.87% | -94.52% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -100.00% | 129.71% | 15.87% |
| Cash from Investing | -100.64% | -100.05% | -100.48% | 129.44% | 15.60% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | 15,348.81% | 1,125.81% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 290.97% | -100.83% | 15,348.81% | 1,125.81% | -183.51% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -131.49% | -139.76% | 1,231.91% | 87.26% | 721.44% |